Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 42582-300

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 42582-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bi-coastal Pharmaceutical Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure 1 (Chlordiazepoxide 01)

Chemical structure diagram of Chlordiazepoxide Hydrochloride, showing its molecular arrangement including a chlorophenyl group, nitrogen atoms, and hydrochloride component.*

FDA Label Image

Chemical Structure 2 (Chlordiazepoxide 02)

Chemical structure diagram of Chlordiazepoxide Hydrochloride and Clidinium Bromide showing molecular bonds and functional groups as depicted in the product data.*

FDA Label Image

Principal Display Panel (5 mg / 2.5 mg Bottle Label)

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules, 5 mg / 2.5 mg strength, manufactured by Bi-Coastal Pharmaceutical Corporation. The label indicates the package contains 100 capsules and includes storage instructions and lot/expiration date fields, along with the NDC 42582-300-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.